Reagents/media
Ended Awarded Last action
- Contract number
- 75N91020F00006
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,375
Award facts
- Contract value 100% obligated
- $38,374.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a $38,374.56 delivery order to Roche Diagnostics Corporation on February 27, 2020, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.
Place of performance is Bethesda, MD 20892. The order was firm fixed price with an ultimate completion date of March 28, 2020. No set-aside was used.
Quick answers
Who was awarded contract 75N91020F00006?
75N91020F00006 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on February 27, 2020.
How much is contract 75N91020F00006 worth?
The government has obligated $38,375 on 75N91020F00006.
Is contract 75N91020F00006 an order under another contract?
Yes. 75N91020F00006 is a delivery order under 75N91019D00038, an indefinite delivery contract.
Was contract 75N91020F00006 competed?
The extent of competition for 75N91020F00006 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award